Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-15

Clinical Trial Results: A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial results for AMZ001 in knee osteoarthritis have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMZ001

Snippet

Sponsor: Amzell | Conditions: Osteoarthritis of Knee, Osteoarthritis, Knee | Phase 3 | Status: COMPLETED | Results posted: 2026-07-15